17 results
DEFR14A
fhx669ajv lkbd
5 May 21
Revised proxy
4:16pm
8-K
EX-99.1
hc6yfg4gflktb
21 Feb 12
Conference Call Today 10 a.m. EST
12:00am
8-K
EX-99.1
eqg92z wittbi85
20 Dec 11
Repligen Completes Acquisition of Novozymes Biopharma Sweden AB
12:00am
8-K
EX-99.1
lettd2vl1rl3oqen5u
28 Oct 11
Entry into a Material Definitive Agreement
12:00am
8-K
EX-99.2
aci ilx2y
28 Oct 11
Entry into a Material Definitive Agreement
12:00am
8-K
EX-99.1
pm7cg6opgg9yowr9n7e
27 Oct 11
Vice President, Market Development
12:00am
8-K
EX-99.1
oq6ajngv2 o9aesfp8
25 Aug 09
Repligen Elects Glenn L. Cooper, M.D. to the Board of Directors
12:00am
8-K
EX-99.1
qc4yoewg33 usf5689
6 Aug 09
Repligen Reports First Quarter Fiscal Year 2010 Financial Results
12:00am
8-K
EX-99.1
9reryj 2ck
11 Jun 09
Repligen Reports Fourth Quarter and Fiscal Year 2009 Financial Results
12:00am
8-K
EX-99.1
15ib 7jtz5v
27 Jul 05
Results of Operations and Financial Condition
12:00am
8-K
EX-99.1
uctji1d4wycduky3txgk
6 Oct 99
Current report
12:00am
- Prev
- 1
- Next